SHFH — Scientist Home Future Health Ltd

OTC · Materials · Chemicals · CIK 2032609 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
Scientist Home Future Health Limited engages in the retail trading of health supplements and topical creams in Hong Kong and internationally. The company offers Scientist Home Vein Cream, for supporting vein health; Scientist Home Calcification Cream for addressing calcification problems associated with bone, joint and muscle health, as well as the cardiovascular system; and Scientist Home Spermaceti Cream, which targets joint and muscle discomfort for arthritis, tendon and ligament strains, and minor sprains and bruises. It also provides Scientist Home Bone Gelatine Hydrolysate, a nutritional supplement which helps to maintain and enhance bone and joint health; Scientist Home Mixed Gelatine Hydrolysate, a supplement that promotes bone and joint health; and Scientist Home High Concentration Proteinase, a supplement that supports various health needs, including bone and joint discomfort, muscle tenderness, airway and lung health, digestive health, intestinal and colon health, and soft tissue injury. The company was incorporated in 2024 and is based in Kwun Tong, Hong Kong.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 188,756 59,068 -102,072 -102,072 558,759 15,332 547,332
Dec 2025 88,075 32,589 -152,726 -152,726 644,365 68,888 530,974
Sep 2025 39,604 16,070 -47,845 -47,845 723,008 275,610 456,004
Jun 2025 31,552 13,539 -38,148 -37,213 114,715 111,386 63,182

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-109,474
Investing CF
Financing CF
$368,443
CapEx
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.00
As of
2026-05-14

Balance + Analyst (yfinance extras)

Retained Earnings
$-93,979
Inventory
$1,991
Receivables
ST Investments
EBIT TTM
$-77,071
Pretax Income TTM
$-77,070
Interest Exp TTM
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$347,987
EBITDA
Free Cash Flow
Enterprise Value
$45,436,064
Total Cash
$15,332
Total Debt
$390,998
Shares Out
23,716,000
Trailing EPS
$-0.01
Book Value
ROE
ROA
Div Yield

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 204,055 -231,725 -231,725 644,365 530,974 -248,278
Dec 2024 21,248 27,268

Peers — same industry

TickerNameMarket CapLastDaily %
PG PROCTER & GAMBLE Co $332.90B $142.96
LIN LINDE PLC $238.09B $514.97
UL UNILEVER PLC $123.97B $57.07
CL COLGATE PALMOLIVE CO $71.90B $89.85
ECL ECOLAB INC. $71.55B $254.23

Recent Insider Activity

No insider activity indexed for this ticker.